| 2A24 | A: | HADDOCK STRUCTURE OF HIF-2A/ARNT PAS-B HETERODIMER |
| 3F1N | A: | CRYSTAL STRUCTURE OF A HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS, WITH INTERNALLY BOUND ETHYLENE GLYCOL. |
| 3F1O | A: | CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS, WITH AN INTERNALLY-BOUND ARTIFICIAL LIGAND |
| 3F1P | A: | CRYSTAL STRUCTURE OF A HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS |
| 3H7W | A: | CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS WITH THE ARTIFICIAL LIGAND THS017 |
| 3H82 | A: | CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS WITH THE ARTIFICIAL LIGAND THS020 |
| 4GHI | A: | CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS IN COMPLEX WITH A BENZOXADIAZOLE ANTAGONIST |
| 4GS9 | A: | CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS IN COMPLEX WITH AN INACTIVE BENZOXADIAZOLE ANTAGONIST |
| 4H6J | A: | IDENTIFICATION OF CYS 255 IN HIF-1 AS A NOVEL SITE FOR DEVELOPMENT OF COVALENT INHIBITORS OF HIF-1 /ARNT PASB DOMAIN PROTEIN-PROTEIN INTERACTION. |
)
)